Larry Adam, Raymond James chief investment officer, joins 'The Exchange' to discuss key takeaways from Big Tech earnings, ...

January finished with an earthquake in the tech world, when the Chinese startup DeepSeek released its new AI assistant – and ...

This was the stock's second consecutive day of gains.

Raymond James is seeing a beneficial shift to advisory as well as recovering M&A activity, which may continue. Read why I ...

Booz Allen Hamilton Holding ( NYSE: BAH) on Monday was upgraded to Outperform from a previous investment rating of Market ...

LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...

Raymond James lowered their FY2025 earnings per share (EPS) estimates for West Fraser Timber in a research report issued on Monday, February 3rd. Raymond James analyst D. Swetlishoff now anticipates ...

Equities research analysts at Raymond James boosted their FY2025 earnings per share (EPS) estimates for Medexus Pharmaceuticals in a report released on Monday, February 3rd. Raymond James analyst M.

Raymond James analyst James Rollyson raised the firm’s price target on NOV Inc. (NOV) to $19 from $18 and keeps an Outperform rating on the ...

Fintel reports that on February 6, 2025, Raymond James downgraded their outlook for Symbotic (NasdaqGM:SYM) from Outperform ...

Following similar moves by other large firms, Raymond James says quarterly advisor counts aren’t the most meaningful measure ...

In earnings calls, both Raymond James and Ameriprise cited strong recruiting pipelines as they beat analysts’ income ...